Abstract:Olaquindox, N-(2-hydroxyethyl)-3-methyl-2-quinoxalinecarboxamide-1,4-di-N-oxide, is one of the quinoxaline-dioxides used widely as an antimicrobial growth promoter in pig production. Its toxicities were reported to be closely related to the formation of N-oxide reductive metabolites. The present study presents the metabolism and N-oxide reduction of olaquindox incubated with liver microsomes and liver cytosol of rats, pigs and chicken. Metabolites were identified and characterized with a novel LC/MS-ITTOF. Thirteen metabolites were found in liver microsomes of rats, three of which were identified to be novel. Seven metabolites were found in liver microsomes of pigs and chicken. The N-oxide reduction was the major metabolic pathway of olaquindox in liver microsomes of the three species. The N1-reduction of olaquindox to metabolite O2 was found in not only liver microsomes but also cytosol of the three species in the presence of NAD(P)H under hypoxic conditions. The N1-reduction could be inhibited by air and carbon monoxide, and be significantly stimulated by riboflavin under various conditions. The N1-reduction in the liver cytosol of rats and pigs could be enhanced by menadione, but the reduction in liver cytosol of chicken could not be. The N1-reduction activities in all animals were not abolished when liver microsomes and cytosol were boiled. These findings suggested that the N1-reduction of olaquindox could be mediated by non-enzymatic and enzymatic conditions. This N1-reduction of olaquindox could also be catalyzed by a quinone-dependent reducing system in liver cytosol of rats and pigs. Moreover, liver cytosol of rats and pigs had an ability of N4-reduction that catalyzed olaquindox to metabolite O1 in the presence of benzaldehyde under hypoxic conditions, but the liver cytosol of chicken did not. The N4-reduction could be inhibited markedly in the cytosol rats and pigs by menadione, chlorpromazine and promethazine. In addition, 7-hydroxycoumarin was also found to inhibit the formation of O1 in the cytosol of rats. The inhibitory results suggested that the N4-reduction might be catalyzed by aldehyde oxidase in the cytosol of pigs, and by aldehyde oxidase and xanthine oxidase in the cytosol of rats. In conclusion, the N1-reduction and N4-reduction of olaquindox are mediated by multiple mechanisms and significant species differences are involved in both reductions. This work is a contribution to the understanding of toxicities and the relativities between toxicities and metabolism of olaquindox.

Olaquindox-Induced Liver Damage Involved the Crosstalk of Oxidative Stress and p53 In Vivo and In Vitro

Critical Role of P21 on Olaquindox-Induced Mitochondrial Apoptosis and S-phase Arrest Involves Activation of PI3K/AKT and Inhibition of Nrf2/HO-1pathway.

Molecular mechanism of olaquindox-induced hepatotoxicity and the hepatic protective role of curcumin

Olaquindox Induces Apoptosis Through the Mitochondrial Pathway in HepG2 Cells.

Effect of GADD45a on Olaquindox-Induced Apoptosis in Human Hepatoma G2 Cells: Involvement of Mitochondrial Dysfunction.

Gadd45a Regulates Olaquindox-Induced Dna Damage and S-Phase Arrest in Human Hepatoma G2 Cells Via Jnk/P38 Pathways

Olaquindox-Induced Genotoxicity and Oxidative Dna Damage in Human Hepatoma G2 (hepg2) Cells

Olaquindox-induced Apoptosis is Suppressed Through P38 MAPK and ROS-mediated JNK Pathways in HepG2 Cells

Reactive oxygen species-dependent JNK downregulated olaquindox-induced autophagy in HepG2 cells.

Administration of olaquindox impairs spermatogenesis and sperm quality by increasing oxidative stress and early apoptosis in mice

Lipoic Acid Protected PC12 Cells from Oxidative Stress-induced Damage by inhibiting the NF-κB-iNOS-NO Signal Pathway

The metabolism and N-oxide reduction of olaquindox in liver preparations of rats, pigs and chicken.

Involvement of P53 in Oroxylin A-induced Apoptosis in Cancer Cells.

Quinocetone-induced Nrf2/HO-1 pathway suppression aggravates hepatocyte damage of Sprague–Dawley rats

Oxidative Damage of Mitochondria by Olaquindox in HepG2 Cells

Oroxylin A Modulates Mitochondrial Function and Apoptosis in Human Colon Cancer Cells by Inducing Mitochondrial Translocation of Wild-Type P53

Metabolism of olaquindox in rat and identification of metabolites in urine and feces using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.

Tcs2 Increases Olaquindox-Induced Apoptosis by Upregulation of Ros Production and Downregulation of Autophagy in Hek293 Cells

P53 Activation Contributes to Patulin-Induced Nephrotoxicity Via Modulation of Reactive Oxygen Species Generation

Effects of p38 MAPK signaling pathway on apoptosis stimulated by olaquindox in human hepatoma G2 cells

Metabolism of olaquindox in rat liver microsomes: structural elucidation of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry.